Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
439,773
-
Shares change
-
-118,041
-
Total reported value, excl. options
-
$30,048,000
-
Value change
-
-$8,065,052
-
Number of sells
-
-8
-
Price
-
$68.33
Significant Holders of NOVOZYMES A S DKK 2.0 - COM as of Q3 2021
8 filings reported holding B798FW902 - NOVOZYMES A S DKK 2.0 - COM as of Q3 2021.
NOVOZYMES A S DKK 2.0 - COM has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 439,773 shares
.
Largest 8 shareholders include SOMERVILLE KURT F (128,250 shares), Hemenway Trust Co LLC (96,725 shares), Broderick Brian C (69,519 shares), PUZO MICHAEL J (54,440 shares), Kidder Stephen W (37,940 shares), Notis-McConarty Edward (21,085 shares), Page Arthur B (18,940 shares), and Dempze Nancy E (12,874 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.